Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Total Non-Current Liabilities (2020 - 2021)

Rani Therapeutics Holdings' Total Non-Current Liabilities history spans 2 years, with the latest figure at $2.6 million for Q4 2021.

  • On a quarterly basis, Total Non-Current Liabilities fell 65.8% to $2.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was $2.6 million, a 65.8% decrease, with the full-year FY2021 number at $2.6 million, down 65.8% from a year prior.
  • Total Non-Current Liabilities came in at $2.6 million for Q4 2021, down from $5.2 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $9.4 million in Q2 2021, with the low at $2.6 million in Q4 2021.